Skip to main content

RxSight, Inc.

RXST
Exchange
Nasdaq
Industry
Ophthalmic Goods
SEC CIK
0001111485

In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding RxSight, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of RXST: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5358+5
Shares9.11M9.61M+502.1K (+5.5%)
Value$109.3M$121.6M+$12.3M (+11.3%)

New holders (11)

Institutions that held RxSight, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to RXST in Q4 2022
InstitutionSharesValue% of portfolio
Next Century Growth Investors LLC648,095$8.21M0.99%
Altium Capital Management LP50,586$640.9K0.33%
Schonfeld Strategic Advisors LLC47,800$605.6K0.01%
LPL Financial LLC32,058$406.2K0.00%
Mill Creek Capital Advisors, LLC19,877$251.8K0.01%
Creative Capital Management Investments LLC3,220$41.0K0.04%
MCF Advisors LLC784$9.93K0.00%
Point72 Middle East FZE394$4.99K0.00%
GWM Advisors LLC1,700$220.00%
Nisa Investment Advisors, LLC7$00.00%
Capital Advisors, Ltd. LLC29$00.00%

Sold out (6)

Institutions that held RxSight, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of RXST in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Bridger Management, LLC221,732$2.66M
Sessa Capital IM, L.P.135,779$1.63M
Saturna Capital CORP14,400$173.0K
BNP Paribas Arbitrage, SA6,526$78.3K
Acadian Asset Management LLC1,611$19.0K
Wolff Wiese Magana LLC340$4.00K